A Centronuclear Myopathy-Dynamin 2 Mutation Impairs Skeletal Muscle Structure and Function in Mice
Human Molecular Genetics, 2010, Vol. 19, No. 24 4820–4836 doi:10.1093/hmg/ddq413 Advance Access published on September 21, 2010 A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice Anne-Ce´cile Durieux1,2,3,4, Alban Vignaud1,2,3,4, Bernard Prudhon1,2,3,4, Mai Thao Viou1,2,3,4, Maud Beuvin1,2,3,4, Ste´phane Vassilopoulos1,2,3,4, Bodvae¨l Fraysse1,2,3,4, Arnaud Ferry1,2,3,4, ∗ Jeanne Laine´ 1,2,3,4, Norma B. Romero 1,2,3,4,5, Pascale Guicheney1,6 and Marc Bitoun1,2,3,4, Downloaded from https://academic.oup.com/hmg/article/19/24/4820/680275 by guest on 25 September 2021 1Universite´ Pierre et Marie Curie-Paris 6, IFR14, Paris F-75013, France, 2CNRS, UMR 7215, Paris, France, 3Inserm, U974, Paris F-75013, France, 4Institut de Myologie, Paris, France, 5AP-HP, Groupe Hospitalier Pitie´-Salpeˆtrie`re, Paris F-75013, France and 6Inserm, U956, Paris F-75013, France Received July 1, 2010; Revised and Accepted September 16, 2010 Autosomal dominant centronuclear myopathy (AD-CNM) is due to mutations in the gene encoding dynamin 2 (DNM2) involved in endocytosis and intracellular membrane trafficking. To understand the pathomechanisms resulting from a DNM2 mutation, we generated a knock-in mouse model expressing the most frequent AD- CNM mutation (KI-Dnm2R465W). Heterozygous (HTZ) mice developed a myopathy showing a specific spatial and temporal muscle involvement. In the primarily and prominently affected tibialis anterior muscle, impair- ment of the contractile properties was evidenced at weaning and was progressively associated with atrophy and histopathological abnormalities mainly affecting mitochondria and reticular network.
[Show full text]